Magdalena Wygralak
Canada has announced a deal to secure 500K doses of GSK’s (NYSE:GSK) avian influenza vaccine for humans as the country steps up efforts to protect at-risk individuals and bolster its federal stockpile as part of national preparedness.
The Public Health